Report #2867734

Received Oct 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 1 yrs
State: OH
Recovered: Unknown
Vaccinated: Jul 22, 2025
Onset: Jul 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPIPV	DTAP + IPV (KINRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	3RT93	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Underage; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 17-month-old male patient who received DTPa-IPV (Kinrix) (batch number 3RT93, expiry date 03-APR-2026) for prophylaxis. On 22-JUL-2025, the patient received the 1st dose of Kinrix. On 22-JUL-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Underage). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-SEP-2025 The nurse reported that a 17-month-old had been administered Kinrix. It had been the child's first dose of DTaP and IPV.